The European Medicines
Agency’s Committee for Medicinal
Products for Human Use (CHMP)
has recommended marketing
authorisation for GSK’s Mekinist
(trametinib) for the treatment of
metastatic melanoma under certain
conditions.
Bayer’s Nexavar (sorafenib) has
been granted extended use to
include thyroid cancer in specific
situations.
New restrictions have been
placed on Linoladiol creams and
domperidone-containing medicines
while new advice has been given
around the use of zolpidemcontaining
medicines.
For details, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Apr 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.